Physician profile
David L Taylor
NPI 1871593947
$68,132.76
in general payments reported to CMS, 2019-2025
46 companies · $30K in 2025
The $30K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,461 · 2020: $165 · 2021: $320 · 2022: $10K · 2023: $8,558 · 2024: $13K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Food and Beverage: $10K · Honoraria: $5,300 · Consulting Fee: $5,143 · Travel and Lodging: $2,339 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,770.00 |
| Food and Beverage | $10,323.73 |
| Honoraria | $5,300.00 |
| Consulting Fee | $5,143.00 |
| Travel and Lodging | $2,339.13 |
| Education | $175.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $31,359.16 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Dendreon Pharmaceuticals LLC | $7,493.27 | 2020-2025 | Provenge |
| Progenics Pharmaceuticals, INC. | $5,641.88 | 2021-2025 | Pylarify |
| Integra Gpo, LLC | $4,986.08 | 2019 | |
| Avyxa Pharma, LLC | $3,798.71 | 2025 | |
| Myriad Genetic Laboratories, INC. | $3,453.22 | 2022-2024 | Myrisk, Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $3,428.86 | 2019-2025 | |
| Immunitybio, INC. | $2,937.36 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $1,197.52 | 2024-2025 | Adstiladrin |
| Pfizer INC. | $487.60 | 2019-2025 | |
| Astellas Pharma US INC | $416.35 | 2019-2025 | Xtandi |
| Calyxo, INC. | $294.62 | 2025 | Cvac Aspiration System |
| Telix Pharmaceuticals | $290.24 | 2023-2025 | Illuccix |
| Merck Sharp & Dohme LLC | $217.39 | 2019-2025 | Lynparza |
| Urogen Pharma, INC. | $179.01 | 2023-2024 | Jelmyto |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $171.70 | 2022-2025 | Botox, Lupron Depot |
| Procept Biorobotics Corporation | $171.44 | 2022 | |
| Coloplast Corp | $170.87 | 2023-2025 | Speedicath |
| Foundation Medicine, INC. | $153.15 | 2022-2023 | |
| Endo Pharmaceuticals INC. | $136.57 | 2023 | Xiaflex, Aveed |
| Novartis Pharmaceuticals Corporation | $131.13 | 2023-2025 | |
| Genzyme Corporation | $121.88 | 2021 | |
| Janssen Scientific Affairs, LLC | $121.82 | 2025 | Erleada |
| Olympus America INC. | $83.29 | 2025 | Soltive |
| Sumitomo Pharma America, INC. | $74.42 | 2023-2024 | Orgovyx, Gemtesa |
| Astrazeneca Pharmaceuticals LP | $66.32 | 2021-2025 | Imfinzi |
| Blue Earth Diagnostics | $64.92 | 2023-2025 | Posluma |
| Ethicon US, LLC | $48.02 | 2019-2025 | Echelon Flex |
| Agiliti Surgical, INC. | $46.85 | 2023 | Sonablate, Trinity |
| Amgen INC. | $45.18 | 2022 | |
| Sun Pharmaceutical Industries INC. | $35.66 | 2022 | |
| Endo USA, INC. | $34.69 | 2025 | Xiaflex, Aveed |
| Myovant Sciences INC. | $31.15 | 2022 | |
| Boston Scientific Corporation | $28.59 | 2020-2023 | |
| Tolmar Pharmaceuticals, INC. | $26.85 | 2020 | |
| Tempus Ai, INC | $23.61 | 2025 | Xt Cdx |
| Accord Healthcare, INC. | $21.14 | 2022 | |
| Tolmar, INC. | $18.98 | 2024 | |
| Ambu INC. | $17.82 | 2021 | |
| Mimedx Group, INC. | $17.68 | 2025 | |
| Antares Pharma, INC. | $17.01 | 2025 | Xyosted |
| C. R. Bard, INC. & Subsidiaries | $16.16 | 2025 | Bard Urinary Drainage Bag |
| Janssen Pharmaceuticals, INC | $15.15 | 2025 | Erleada |
| Allergan, INC. | $14.88 | 2019 | |
| Urovant Sciences INC | $12.56 | 2022 | |
| Abc Home Medical Supply, INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.